Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6
about
Current stage in inflammatory bowel disease: What is next?Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorDiscovery and characterization of olokizumabSoluble cytokine receptors: basic immunology and clinical applications.Expression of interleukin 6 in brain and colon of rats with TNBS-induced colitis.Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitisEffects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitisProfile of soluble cytokine receptors in Crohn's disease.Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phaseFactors associated with inflammation markers, a cross-sectional analysis.Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides.STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.Novel therapy for Crohn's disease targeting IL-6 signalling.Cytokine signal regulation and autoimmune disorders.Study of the mechanisms of acupuncture and moxibustion treatment for ulcerative colitis rats in view of the gene expression of cytokinesInterleukin-6 in aging and chronic disease: a magnificent pathwayNovel strategies for the treatment of inflammatory bowel disease: Selective inhibition of cytokines and adhesion moleculesThe IL-6/sIL-6R complex as a novel target for therapeutic approaches.Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxideAnti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases.Cytokine blockade in inflammatory bowel diseases.Immunotherapeutic implication of IL-6 blockade.Changes of the cytokine profile in inflammatory bowel diseases.Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel.From physiology to disease and targeted therapy: interleukin-6 in inflammation and inflammation-associated carcinogenesis.Cytokines in inflammatory bowel disease.Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptorOxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients.The role of the hypothalamic-pituitary-adrenal axis in modulating seasonal changes in immunity.Interleukin 6 inhibition by triptolide prevents inflammation in a mouse model of ulcerative colitis.A multiscale model of interleukin-6-mediated immune regulation in Crohn's disease and its application in drug discovery and development.Specific targeting of IL-6 signalling pathway: a new way to treat IBD?Identification of a novel substance P (SP)-neurokinin-1 receptor (NK-1R) microRNA-221-5p inflammatory network in human colonic epithelial cells.Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone MassC-reactive protein: a physiological activator of interleukin 6 receptor shedding.Role of cytokines in inflammatory bowel disease.Cytokines in inflammatory bowel disease.Serum Amyloid A as a Surrogate Marker for Mucosal and Histologic Inflammation in Patients with Crohn's Disease.No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.Immunological pathogenesis of inflammatory bowel disease.
P2860
Q26777429-EDB7FD38-7A2C-4AFB-8B9B-8F117D93C4E4Q27022976-69707EA2-DF4D-4BA6-9DC0-BBE6C3EB0D05Q27682535-82F7ECB8-86F2-40C2-A1AC-C622849DC31AQ33688222-25E07BC8-0190-4079-8348-6EED8F381F84Q33844173-B50B5AA8-FFCD-4D80-9535-5CE477D0568DQ34116480-5C574B2D-EA22-48C2-B047-C7698142459DQ35062006-C349C790-2B87-49A3-91DD-2BCFB086D899Q35597272-7A981EC7-A4CB-4ACE-95D9-9086EBFEB040Q35598569-9CF9454B-4511-43E3-8A93-568CECBFB66FQ35633792-78B9CD49-5958-4BDD-AF14-725B7074541DQ35694271-E7E47F23-5CFC-45F1-8E03-3CA876AAC262Q35769017-7E98F754-AE93-4676-8C9F-DCD2475821B2Q35842497-6734ED10-9EF3-4D7B-8BE4-8316D3A61860Q36287536-F36DC1AD-F223-4E45-BEBF-40DCE341D159Q36397576-75948807-132D-4DAE-86B7-80BC16BBD887Q36518670-819EE931-E9CD-4D43-9698-FCD3B1C96E9AQ36579737-509CCD8D-AF78-4BEF-BB4F-58140083A398Q36804420-72514770-C252-4CAF-AF73-B50101BDE007Q37269957-BE2E077A-0CC4-45DF-9A75-EAFC6A5DD537Q37854935-21B97143-782B-4C74-B129-EA85DC38EEA7Q37952792-5C3EA42F-D929-4000-8ED5-47327C82332CQ37965754-53086269-C02A-4114-9E60-1B777469D9BAQ38058782-FF98329F-025C-41A8-9679-A87B860C90FCQ38253468-F7DF116F-2E69-4E1C-8E77-2051312EEC80Q38336406-F1378836-31ED-477A-9B21-97504AD43CD3Q38960468-B2CA1971-11C0-4D29-B8FC-4302F7639421Q39459586-9D71405F-F220-4694-8E92-9EDEFDCB261AQ39509175-18C1914E-EE84-4817-B3BF-9B29E8BEC862Q39656925-014C61A2-B37E-4E12-B019-46C3667E7F56Q41672388-D8FB548F-EA12-461E-BF1C-7532DD79074FQ41906100-5A95F021-A4FC-4D28-946A-8BCC10061A03Q42124575-33F5DAA9-9DE9-4282-B805-5979E1E51CFDQ42252901-81F411C3-319B-4FD7-AAD4-1079F9F352E9Q42380690-E73D7E1F-0440-4552-864A-242D0F58666BQ42943901-F7BB4972-F290-47D8-903C-1BCF067E226FQ43065113-439E2EE5-1920-4161-BDCF-12B39C37866FQ43204450-6E084EB9-4C50-4FCE-A066-1E680234F0F9Q45992381-7882F74F-1018-4F31-8772-DC3ADD74D79CQ47443055-722AF71B-60E9-42C6-BE53-AF57003FE591Q50042967-4F2B1447-53A3-4C3E-A7B6-FA97F1A7B9AF
P2860
Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@ast
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@en
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@nl
type
label
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@ast
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@en
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@nl
prefLabel
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@ast
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@en
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@nl
P2093
P2860
P921
P356
P1433
P1476
Soluble interleukin-6 receptor ...... n to circulating interleukin-6
@en
P2093
Mitsuyama K
Nishiyama T
Tanikawa K
Tateishi H
Toyonaga A
P2860
P356
10.1136/GUT.36.1.45
P407
P577
1995-01-01T00:00:00Z